WIC
NVS icon

Whitegate Investment Counselors’s Novartis NVS Stock Holding History

Whitegate Investment Counselors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25,222
Closed -$2.06M – 158
2021
Q3 		$2.06M Sell
25,222
-850
-3% -$76.5K 0.29% 81
2021
Q2 		$2.38M Sell
26,072
-375
-1% -$33.4K 0.34% 76
2021
Q1 		$2.26M Sell
26,447
-350
-1% -$31.4K 0.34% 74
2020
Q4 		$2.53M Sell
26,797
-2,150
-7% -$188K 0.41% 63
2020
Q3 		$2.52M Hold
28,947
– – 0.46% 61
2020
Q2 		$2.53M Sell
28,947
-150
-0.5% -$12.9K 0.51% 63
2020
Q1 		$2.4M Sell
29,097
-2,250
-7% -$201K 0.58% 56
2019
Q4 		$2.97M Sell
31,347
-125
-0.4% -$11.2K 0.54% 63
2019
Q3 		$2.73M Sell
31,472
-543
-2% -$48.8K 0.54% 65
2019
Q2 		$2.92M Sell
32,015
-11,259
-26% -$953K 0.59% 64
2019
Q1 		$3.73M Sell
43,274
-3,817
-8% -$306K 0.77% 43
2018
Q4 		$3.62M Sell
47,091
-530
-1% -$41.3K 0.84% 38
2018
Q3 		$3.68M Buy
47,621
+6
+0% +$444 0.75% 44
2018
Q2 		$3.22M Buy
47,615
+167
+0.4% +$11.5K 0.66% 52
2018
Q1 		$3.44M Buy
47,448
+246
+0.5% +$18.7K 0.73% 43
2017
Q4 		$3.55M Sell
47,202
-1,111
-2% -$83.8K 0.74% 42
2017
Q3 		$3.72M Buy
48,313
+56
+0.1% +$4.23K 0.82% 38
2017
Q2 		$3.61M Buy
48,257
+112
+0.2% +$7.94K 0.82% 38
2017
Q1 		$3.2M Sell
48,145
-921
-2% -$61.4K 0.77% 42
2016
Q4 		$3.2M Sell
49,066
-74
-0.2% -$4.8K 0.86% 38
2016
Q3 		$3.48M Sell
49,140
-1,451
-3% -$106K 0.95% 33
2016
Q2 		$3.74M Buy
+50,591
New +$3.5M 1.04% 32
2014
Q1 		$3.15M Buy
+48,582
New +$3.54M 0.86% 39

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Whitegate Investment Counselors's NVS Position: Q4 2021 in Review

Whitegate Investment Counselors sold out of Novartis (NVS) in Q4 2021, closing a stake of 25,222 shares — an estimated $2.06M sold.

Whitegate Investment Counselors first reported a position in NVS in Q1 2014 and held it in 23 quarters. The position peaked at $3.74M in Q2 2016. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

  • Whitegate Investment Counselors reported no remaining Novartis position as of Q4 2021 after selling out during the quarter.
  • Whitegate Investment Counselors sold 25,222 Novartis shares in Q4 2021, an estimated $2.06M.
  • Whitegate Investment Counselors first reported a position in Novartis in Q1 2014 and held it in 23 quarters.
  • Whitegate Investment Counselors's Novartis position peaked at $3.74M in Q2 2016.
  • 1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Whitegate Investment Counselors's 13F filing for Q4 2021, filed 3 Feb 2022.